Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Metastatic Castration-Resistant Prostate Cancer × apalutamide × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 33 Stage II Prostate Adenocarcinoma 1 Salivary Gland Neoplasms 1 Non-Muscle Invasive Bladder Urothelial Carcinoma 1 Neoplasm Metastasis 1 Metastatic Hormone-sensitive Prostate Cancer 1 Metastatic Castration-resistant Prostate Neoplasms 1 Metastatic Castrate-sensitive Prostate Cancer 1 Castration Levels of Testosterone 1 Adenocarcinoma 1

Interventions

enzalutamide 3 Docetaxel 2 pembrolizumab 1 olaparib 1 lenvatinib 1 inavolisib 1 belzutifan 1 abiraterone 1 Prednisone 1 PF06821497 1 Lutetium-177 1 Lutetium 1 Gonadotropin-Releasing Hormone 1 Etoposide 1 Diagnostic Tests, Routine 1 Dexamethasone 1 Carboplatin 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡